The differences between the MARCO and SR-A1 structures (By Figdraw).

€ 13.00 · 4.6 (584) · En stock

Por un escritor de hombre misterioso

Download scientific diagram | The differences between the MARCO and SR-A1 structures (By Figdraw). MARCO has a longer collagenous domain and does not have the α-helical coiled-coil domain that is present in SR-A1; MARCO directly binds ligands via the SRCR domain, whereas SR-A1 primarily binds ligands through its collagenous domain from publication: The application of MARCO for immune regulation and treatment | Macrophage receptor with collagen structure (MARCO) is a member of scavenger receptor class A (SR-A) and shares structural and functional similarities with SR-A1. In recent years, many studies have shown that MARCO can trigger an immune response and has therapeutic potential | Immunochemistry, Immunotherapy and B Cells | ResearchGate, the professional network for scientists.

SIRT3 alleviates high glucose-induced chondrocyte injury through the promotion of autophagy and suppression of apoptosis in osteoarthritis progression - ScienceDirect

MARCO - Wikipedia

The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease

2-Ethylhexyl Diphenyl Phosphate Causes Obesity in Zebrafish by Stimulating Overeating via Inhibition of Dopamine Receptor D2

Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions

Expression of scavenger receptor MARCO defines a targetable tumor‐associated macrophage subset in non‐small cell lung cancer - La Fleur - 2018 - International Journal of Cancer - Wiley Online Library

PDF) Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Pan-cancer structurome reveals overrepresentation of beta sandwiches and underrepresentation of alpha helical domains

Recent advances in EZH2-based dual inhibitors in the treatment of cancers - ScienceDirect

The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease

Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions

BJNANO - Search Results

Frontiers Regulation of microglia phagocytosis and potential involvement of exercise